Clinical Trial Update: A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS [Phase 2]

View source ↗

Summary

Phase II study assessing the safety and efficacy of clarithromycin for disseminated Mycobacterium avium complex infection in patients with AIDS has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mycobacterium Avium Complex Infection

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections | Phase 2 | Status: COMPLETED